Haemanthus
A blood-testing startup whose patent was public for 109 days before the first news story.
Updated · 13 sources · Markdown
Haemanthus is an Austin startup that says it uses lasers to detect disease in blood, saliva and urine. Its first patent was public from January 21, 2025, 109 days before the first news stories. Its chief executive is Billy Evans, the partner of Theranos founder Elizabeth Holmes; the company says Holmes has no role in it.
Patent was public 109 days before the first press.
- Patent → first press
- 109 daysJan 21, 2025 to May 10, 2025Patent US12203862B1 ↗First press: The New York Times ↗
- Based in
- Austin, TX
- Founders
- Billy EvansChief executive
The record behind the timing: Patent, Jan 21, 2025

The paper trail
Dated records in order, each with its source. Certificate validity starts can precede CT logging, so they do not always establish an exact first-public date.
What the site says todayHaemanthus reads the complete molecular story of health. Detecting disease earlier. Saving lives.
- Incorporation filing
Haemanthus, Inc. registered in Texas
Newsweek reported that records it reviewed show Haemanthus, Inc. registered in Texas in February 2024 as a foreign for-profit corporation.
Sources1newsweek.com - Patent
Patent priority date
Google Patents lists March 1, 2024 as the priority date of the company's first patent.
Sources1Patent US12203862B1 - 123 days laterPatent
Patent application filed
Application 18/762,412, "Raman spectroscopy system", was filed by Haemanthus Inc. The inventors are Joseph G. LaChapelle and Roger S. Cannon.
Sources1Patent US12203862B1 - 77 days laterPatent
Inventors assign the application to Haemanthus, Inc.
The assignment from LaChapelle and Cannon to the company is dated September 17, 2024.
Sources1Patent US12203862B1 - 119 days laterPatent
Fifth related application filed
Between July 16, 2024 and January 14, 2025 the same two inventors filed four more Raman spectroscopy applications assigned to Haemanthus.
- Patent
US patent 12,203,862 granted and published
From this day the company's name, its inventors and a description of its laser system were public on the patent record.
Sources1Patent US12203862B1 - 109 days laterFirst press · The New York Times
Elizabeth Holmes’s Partner Has a New Blood-Testing Start-Up
Sources1nytimes.com - Public record
Company responds on X
NPR and Fortune quoted the company's account: "Elizabeth Holmes has zero involvement in Haemanthus," and "she has no role, now or future." It named Billy Evans as its CEO.
- Subdomain certificate
Certificate issued for www.haemanthus.com
Certificate transparency logs show the first certificate for the www host twelve days after the first stories. The domain had been a parked for-sale page as late as 2022.
- 298 days laterFounder departure
Chief technology officer says he resigned
Joseph LaChapelle, an inventor on the patent, told Forbes he resigned on March 16, 2026, as quoted by Fortune.
Sources1fortune.com - 50 days laterPatent
Second patent granted
US 12,618,714, "Raman spectroscopy system with standoff detection", was granted to Haemanthus with the same two inventors.
Sources1Patent US12618714B2
The records themselves
Captures of the other public documents behind the trail. Each one links to the full record at its source.

Subdomains
Public certificate records can reveal hostnames before a product is announced. Wildcards can hide individual hosts; a certificate alone does not establish that a service is running. Exact first CT appearances have not been independently confirmed for every host.
www.haemanthus.comcertificate recordmqtt.dev.haemanthus.comcertificate recordsupabase.dev.haemanthus.comcertificate recordapp.dev.haemanthus.comcertificate record
The founder
What we don't know
- Whether the technology works. Fortune reported in October 2026 that the company had no product on sale and no published data.
- How much it has raised. Reported figures range from $3.5 million to as much as $20 million, and no SEC Form D was found.
- When the company was first formed. The Texas registration is as a foreign corporation, so it was formed elsewhere first.
- Who its investors are.
Sources
- newsweek.com/elizabeth-holmes-partner-rakes-millions-new-blood-test-machine-2070573
- patents.google.com/patent/US12203862B1/en
- patents.google.com/patent/US20250277699A1/en
- patents.google.com/patent/US12618714B2/en
- patents.google.com/patent/US20250277744A1/en
- patents.google.com/patent/US20250277745A1/en
- nytimes.com/2025/05/10/business/elizabeth-holmes-partner-blood-testing-startup.html
- npr.org/2025/05/10/nx-s1-5393950/elizabeth-holmes-theranos-billy-evans-blood-testing
- fortune.com/2025/05/12/theranos-elizabeth-holmes-billy-evans-haemanthus-blood-testing-startup/
- crt.sh/?q=haemanthus.com
- web.archive.org/web/20220308205137/http://haemanthus.com/
- fortune.com/2026/10/25/elizabeth-holmes-partner-billy-evans-haemanthus-blood-testing-startup-theranos/
- patentimages.storage.googleapis.com/80/3e/99/7a61d00040bb3e/US12203862.pdf#page=7
The Autumn prompt
Build a profile of five early companies, one row each: LuxSemi Inc. (luxsemi.com, assignee of US patent US12640820B1), Instant Expert (new company of Max Kolysh, who founded Dover), Granite Robotics, Inc. (graniterobotics.ai, Delaware, 2026), Fide AI, Inc. (fideai.org, Delaware, 2026) and Haemanthus (blood testing startup, assignee of US patent US12203862B1). For each, find the legal name, what it is building, sector, headquarters, website and what the site says today, founders, every dated public record (incorporation, domain registration, patents with priority, filing and grant dates, SEC Form D, job posts, launch posts), money raised, and the first press article about it with outlet and date.
- Records
- 10
- Signals
- 3
- Sources
- 13